Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, et al. Ipilimumab and a poxviral vaccine targeting prostate -specific antigen in metastatic castration - resistant prostate cancer: a phase 1 dose -escalation trial. Lancet Oncol. 2012; 13(5):501 -8. 33.